ketoprofen and fenofibrate

ketoprofen has been researched along with fenofibrate in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (19.05)18.2507
2000's8 (38.10)29.6817
2010's8 (38.10)24.3611
2020's1 (4.76)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Headey, SJ; Hughes, ML; Laguerre, A; Mohanty, B; Patil, R; Porter, CJ; Scanlon, MJ; Wielens, J; Williams, ML1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Bosca, F; Fortea, JM; Janes, C; Latasa, JM; Millan, F; Miranda, MA; Serrano, G1
Dubertret, L; Jeanmougin, M; Manciet, JR; Petit, A; Sigal, M1
Dompmartin, A; Leroy, D; Louvet, S; Michel, M; Szczurko, C1
Ader, JC; Chouini-Lalanne, N; Marguery, MC; Paillous, N1
Chouini-Lalanne, N; Lhiaubet, V; Paillous, N1
Szebeni, R1
Belmadoui, N; Climent, MJ; Encinas, S; Gil, S; Miranda, MA1
Aboul-Enein, HY; Kruk, I; Kładna, A; Lichszteld, K; Michalska, T1
Kołodziejczyk, MK; Lukosek, M; Nachajski, MJ; Woskowicz, MH; Zgoda, MM1
Kuwatsuka, S; Kuwatsuka, Y; Takenaka, M; Utani, A1
Gil, F; Monteiro, AF; Parente, J; Rato, M1
Fan, G; Liu, J; Ma, C; Ren, C; Shang, Y; Wang, Z; Yang, C; Yang, L; Zhang, J1

Reviews

2 review(s) available for ketoprofen and fenofibrate

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Photosensitivity induced by fibric acid derivatives and its relation to photocontact dermatitis to ketoprofen.
    Journal of the American Academy of Dermatology, 1992, Volume: 27, Issue:2 Pt 1

    Topics: Aged; Bezafibrate; Cross Reactions; Dermatitis, Photoallergic; Drug Eruptions; Female; Fenofibrate; Humans; Hyperlipidemias; Ketoprofen; Male; Middle Aged; Patch Tests

1992

Other Studies

19 other study(ies) available for ketoprofen and fenofibrate

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Characterization of two distinct modes of drug binding to human intestinal fatty acid binding protein.
    ACS chemical biology, 2014, Nov-21, Volume: 9, Issue:11

    Topics: Fatty Acid-Binding Proteins; Fluorescent Dyes; Humans; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Spectrometry, Fluorescence

2014
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
[Contact photoallergic eczema caused by ketoprofen].
    Annales de dermatologie et de venereologie, 1996, Volume: 123, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Contact; Drug Synergism; Female; Fenofibrate; Humans; Ketoprofen; Photosensitivity Disorders; Skin Tests

1996
Photodermatitis from ketoprofen with cross-reactivity to fenofibrate and benzophenones.
    Photodermatology, photoimmunology & photomedicine, 1997, Volume: 13, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Cosmetics; Cross Reactions; Drug Interactions; Female; Fenofibrate; Humans; Hypolipidemic Agents; Ketoprofen; Male; Middle Aged; Patch Tests; Photosensitivity Disorders; Photosensitizing Agents; Structure-Activity Relationship; Sunscreening Agents; Ultraviolet Rays

1997
Comparison of the DNA damage photoinduced by fenofibrate and ketoprofen, two phototoxic drugs of parent structure.
    Photochemistry and photobiology, 1998, Volume: 68, Issue:5

    Topics: Bacteriophage phi X 174; Cyclic N-Oxides; DNA Damage; DNA, Superhelical; DNA, Viral; Fenofibrate; Ketoprofen; Photolysis; Photosensitizing Agents; Skin; Spin Labels

1998
Comparison of DNA damage photoinduced by ketoprofen, fenofibric acid and benzophenone via electron and energy transfer.
    Photochemistry and photobiology, 2001, Volume: 74, Issue:5

    Topics: Anticholesteremic Agents; Benzophenones; Cytochrome c Group; DNA; DNA Damage; Electron Spin Resonance Spectroscopy; Fenofibrate; Ketoprofen; Oligodeoxyribonucleotides; Photosensitizing Agents; Polarography

2001
[Cross-reaction potentials of ketoprofen].
    Orvosi hetilap, 2002, May-12, Volume: 143, Issue:19

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Cyclooxygenase Inhibitors; Fenofibrate; Humans; Hypersensitivity; Hypolipidemic Agents; Ketoprofen; Propionates; Suprofen

2002
Photosensitization of thymine nucleobase by benzophenone derivatives as models for photoinduced DNA damage: Paterno-Büchi vs energy and electron transfer processes.
    Chemical research in toxicology, 2004, Volume: 17, Issue:7

    Topics: Benzophenones; DNA Damage; Energy Transfer; Fenofibrate; Ketoprofen; Models, Biological; Photosensitizing Agents; Thymine Nucleotides; Ultraviolet Rays

2004
Scavenging of reactive oxygen species by some nonsteroidal anti-inflammatory drugs and fenofibrate.
    Biopolymers, 2006, Jun-05, Volume: 82, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Electron Spin Resonance Spectroscopy; Fenofibrate; Fluorescence; Free Radical Scavengers; Hydroxyl Radical; Hypolipidemic Agents; Ketoprofen; Luminescent Measurements; Oxygen; Peroxides; Reactive Oxygen Species; Spin Labels; Spin Trapping; Superoxides; Tolmetin

2006
Solubilizing properties of new surface-active agents, products of selective oxyethylation of cholic acid. Part I.
    Polimery w medycynie, 2007, Volume: 37, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chlorates; Diclofenac; Fenofibrate; Gemfibrozil; Hypolipidemic Agents; Ketoprofen; Micelles; Models, Theoretical; Nifedipine; Solubility; Solutions; Surface-Active Agents; Vasodilator Agents; Viscosity

2007
Case of photosensitivity caused by fenofibrate after photosensitization to ketoprofen.
    The Journal of dermatology, 2016, Volume: 43, Issue:2

    Topics: Adult; Cross Reactions; Dermatitis, Photoallergic; Fenofibrate; Humans; Ketoprofen; Male; Patch Tests

2016
Fenofibrate photoallergy - relevance of patch and photopatch testing.
    Contact dermatitis, 2018, Volume: 78, Issue:6

    Topics: Acrylates; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Photoallergic; Facial Dermatoses; Female; Fenofibrate; Humans; Hypolipidemic Agents; Ketoprofen; Middle Aged; Patch Tests; Propanols; Ultraviolet Rays

2018
Simultaneous co-assembly of fenofibrate and ketoprofen peptide for the dual-targeted treatment of nonalcoholic fatty liver disease (NAFLD).
    Chemical communications (Cambridge, England), 2020, May-04, Volume: 56, Issue:36

    Topics: Fenofibrate; Humans; Inflammation; Ketoprofen; Lipid Metabolism; Molecular Structure; Non-alcoholic Fatty Liver Disease; Peptides

2020